| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/10/2004 | EP1395554A1 Substituted carbazoles as inhibitors of spla2 |
| 03/10/2004 | EP1395553A1 Pyrrolidine derivatives as factor xa inhibitors |
| 03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 03/10/2004 | EP1395550A1 Cycloalkenylsulfonamide derivatives |
| 03/10/2004 | EP1395538A1 Vitamin d analogues |
| 03/10/2004 | EP1395289A1 Treatment of neuropathic pain with a n-methyl-d-aspartate (nmda) receptor antagonists |
| 03/10/2004 | EP1395279A2 Use of neublastin polypeptides for treating neuropathic pain |
| 03/10/2004 | EP1395261A2 Pyridylpyrimidine derivatives as effective compounds against prion diseases |
| 03/10/2004 | EP1395260A1 Use of the opioid antagonist naltrexone to prevent and control side effects caused by opioids |
| 03/10/2004 | EP1395259A2 Urazole compounds useful as anti-inflammatory agents |
| 03/10/2004 | EP1395257A1 Macrocycles useful in the treatment of alzheimer's disease |
| 03/10/2004 | EP1395253A2 Treatment of anxiety disorders |
| 03/10/2004 | EP1395251A2 Aminediols as agents for the treatment of alzheimer's disease |
| 03/10/2004 | EP1395247A2 Oxcarbazepine dosage forms |
| 03/10/2004 | EP1395243A2 Encapsulation of nanosuspensions in liposomes and microspheres |
| 03/10/2004 | EP1395242A1 Liquid pharmaceutical composition |
| 03/10/2004 | EP1309335B1 Use of extracts from ginkgo biloba leaves for inducing dreams |
| 03/10/2004 | EP1234043B1 Constructs for delivery of therapeutic agents to neuronal cells |
| 03/10/2004 | EP1177196B1 Heteroaryl diazabicycloalkanes, their preparation and use |
| 03/10/2004 | EP1136477B1 Benzofuran derivatives, process for the preparation of the same and uses thereof |
| 03/10/2004 | EP1100499B1 Use of eletriptan for the prevention of migraine recurrence |
| 03/10/2004 | EP1054673B1 Benzoxazine compounds for enhancing synaptic response |
| 03/10/2004 | EP0994875B1 3-pyridyl-1-azabicycloalkane derivatives for prevention and treatment of cns disorders |
| 03/10/2004 | EP0767634B1 Microcapsules for administration of neuroactive agents |
| 03/10/2004 | CN1481442A Novel primers for screening schizop hrenia and method thereof |
| 03/10/2004 | CN1481383A Method for producing anticholinergic agent tiotropium bromide |
| 03/10/2004 | CN1481380A Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 03/10/2004 | CN1481377A Cyclic Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF alhpa |
| 03/10/2004 | CN1481367A Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 03/10/2004 | CN1481364A Urea and urethane derivatives as integrin inhibitors |
| 03/10/2004 | CN1481360A 蕈毒碱拮抗剂 Muscarinic antagonist |
| 03/10/2004 | CN1481241A Therapeutic combination of amlodipine and benazepril/benazeprilat |
| 03/10/2004 | CN1481236A Aerogel powder comprising therapeutic agents |
| 03/10/2004 | CN1480207A Spore of gandoderma lucidum for treating disease of autoimmunity |
| 03/10/2004 | CN1480200A Penetrating fluid for acupuncture point of electrotherapeutics |
| 03/10/2004 | CN1480170A Formula of headache pill and its preparing method |
| 03/10/2004 | CN1480138A Colored soft eapsule preparation of nimodipine and its preparing method |
| 03/10/2004 | CN1480132A Protective solution for preventing local ischemic damage |
| 03/10/2004 | CN1141123C Medicine for treating rheumatism, rheumatoid disease, lumbar intervertebra disk protrusion, hyperosteogeny and ischias and its prepn process |
| 03/10/2004 | CN1141100C Oily gammariza injection |
| 03/10/2004 | CN1141090C Slowly-releasing magnesium propylvalerate tablet and its preparing process |
| 03/09/2004 | USRE38460 Huperzine A derivatives, their preparation and their use |
| 03/09/2004 | US6703522 Alkyl amino acid derivatives useful as pharmaceutical agents |
| 03/09/2004 | US6703516 Process for the preparation of 5-carboxyphthalide |
| 03/09/2004 | US6703502 Spiroazo bicyclic heterocyclic |
| 03/09/2004 | US6703486 Peripheral nervous system specific sodium channels |
| 03/09/2004 | US6703485 Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof |
| 03/09/2004 | US6703425 Sulfonamide derivatives |
| 03/09/2004 | US6703424 Dispersible compositions containing L-DOPA ethyl ester |
| 03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
| 03/09/2004 | US6703411 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/09/2004 | US6703404 Nitric oxide synthase inhibitors |
| 03/09/2004 | US6703393 Treatment of a variety of central nervous system (cns) disorders in humans, domesticated companion animals and livestock animals. treatment of anxiety, depression, a sleep disorder, attention deficit disorder, or alzheimer's dementia, |
| 03/09/2004 | US6703392 Orexin receptor antagonists for obesity or sleeping disorder treatment |
| 03/09/2004 | US6703391 Quinoxalinedione derivatives, their preparation and use |
| 03/09/2004 | US6703389 Optically pure reboxetine or its methanesulfonate salt inhibits reuptake of norepinephrine |
| 03/09/2004 | US6703383 Antipsychotic sulfonamide-heterocycles, and methods of use thereof |
| 03/09/2004 | US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 03/09/2004 | US6702839 Method of controlling body temperature while reducing shivering |
| 03/09/2004 | US6702803 Multi-step drug dosage forms |
| 03/09/2004 | CA2260016C Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 03/05/2004 | CA2437690A1 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 03/04/2004 | WO2004018669A1 Salt-inducible kinases 2 and use thereof |
| 03/04/2004 | WO2004018598A1 Fat composition |
| 03/04/2004 | WO2004018483A1 Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
| 03/04/2004 | WO2004018482A2 C6- and c9-substituted chromeno[4, 3-c]isoxazoline derivatives and their use as anti-depressants |
| 03/04/2004 | WO2004018476A1 Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| 03/04/2004 | WO2004018474A1 Phenyl-substituted pyrazolopyrimidines |
| 03/04/2004 | WO2004018473A2 Azapurine derivatives |
| 03/04/2004 | WO2004018458A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 03/04/2004 | WO2004018451A1 Pyridazinone-derivatives as pde4 inhibitors |
| 03/04/2004 | WO2004018441A1 Aryl and heteroaryl morpholine derivatives |
| 03/04/2004 | WO2004018440A1 Benzyl morpholine derivatives |
| 03/04/2004 | WO2004018437A1 5-substituted-2-arylpyrazines as modulators of crf receptors |
| 03/04/2004 | WO2004018436A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 03/04/2004 | WO2004018434A1 Pyrimidine compounds |
| 03/04/2004 | WO2004018431A2 Novel phenanthridines |
| 03/04/2004 | WO2004018425A1 N-4-piperidinyl compounds as ccr5 modulators |
| 03/04/2004 | WO2004018422A1 Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists |
| 03/04/2004 | WO2004018412A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 03/04/2004 | WO2004018411A1 Muscarinic agonists |
| 03/04/2004 | WO2004018386A2 Acetophenone potentiators of metabotropic glutamate receptors |
| 03/04/2004 | WO2004018044A2 N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agent |
| 03/04/2004 | WO2004017983A1 Method for the preparation of phytoprogestogenic extracts from rhizoma ligusticum chuanxiong and uses thereof |
| 03/04/2004 | WO2004017977A2 2- (phenoxymethyl)- and 2- (phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors |
| 03/04/2004 | WO2004017973A1 Remedy for integration dysfunction syndrome |
| 03/04/2004 | WO2004017970A1 Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders |
| 03/04/2004 | WO2004017966A1 Five-membered heterocyclic compounds in the treatment of chronic and acute pain |
| 03/04/2004 | WO2004017965A1 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain |
| 03/04/2004 | WO2004017951A1 Use of bupropion for the manufacture of a medicament for treating restless legs syndrome |
| 03/04/2004 | WO2004017950A2 Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents |
| 03/04/2004 | WO2004017946A1 Treating alzheimers using delipidated protein particles |
| 03/04/2004 | WO2004017941A2 Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist |
| 03/04/2004 | WO2004017920A2 Novel biphenyl and biphenyl-like cannabinoids |
| 03/04/2004 | WO2004017906A2 Modulation of matrix metalloproteinase (mmp) activity with aldosterone blocker(s) |
| 03/04/2004 | WO2003106456A3 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 03/04/2004 | WO2003082350A3 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 03/04/2004 | WO2003082216A9 Neuroprotectant methods, compositions, and screening methods thereof |
| 03/04/2004 | WO2003073107A3 Neuropeptide receptor and uses thereof |
| 03/04/2004 | WO2003070760A3 Anti-amyloid beta antibodies and their use |